Listen to Penn Medicine physicians and researchers discuss the latest advances in treatment, research and clinical trials with CureTalks hosts.
We speak with Dr. Courtney Schreiber about current treatment of Rh sensitization, her recent research, which could lead to updated pregnancy care guidelines and help bridge global health equity gaps.
We speak with Dr. Angela DeMichele to understand in depth about why breast cancers recur and learn about approaches being investigated to prevent relapse.
Largest study of palliative care by Drs Scott Halpern and Katherine Courtright, demonstrates that default palliative care consultation is an effective strategy to give more hospitalized patients the opportunity to benefit from palliative care sooner.
Despite advancements in understanding the initial cancer development, the factors driving recurrence of BRCA related breast and ovarian cancers remain elusive, posing a significant challenge in managing the long-term health of mutation carriers.
Fewer than 1000 people in the US have Lecithin cholesterol acyltransferase (LCAT) deficiency. We are speaking with Dr. Marina Cuchel from University of Pennsylvania to understand the condition better.
Dr. Mathias Basner of University of Pennsylvania, studies astronaut behavioral health on long-duration space missions will be discussing various effects of microgravity on human health, cognition, and behavior.
We are speaking with Dr. Amit Bar-Or, director of the Penn MS program to learn about the advances made in diagnosis and treatment of MS and understand how precision medicine can improve quality of life for MS patients.
Mild or moderate COVID-19 lasts for up to 2 weeks for most people. However, many who recovered from the initial infection of COVID-19 and tested negative continue to experience some long-term after effects of the disease.
Schizophrenia is one of the top 15 leading causes of disability throughout the world. We are talking to Dr Monica E. Calkins, Associate Professor of Psychology in Psychiatry at the University of Pennsylvania, to explore early indicators and discuss advances in early identification, prevention and finding more effective treatment of schizophrenia.
We are talking to Dr. Emma A. Meagher, Professor, Medicine and Pharmacology, Vice Dean, Perelman School of Medicine, University of Pennsylvania and VP of University of Pennsylvania Health System, about the basics of clinical research